State regulators crafting crackdown on fake and diverted drugs

01/9/2004 | Wall Street Journal, The

The National Association of Boards of Pharmacy is nearing completion of state guidelines designed to oversee pharmaceutical wholesalers and stop counterfeit and diverted medicines. The plan, now being finalized, likely would require background checks for those seeking licenses as wholesalers and stricter paperwork requirements on a drug's origin.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN